orif is the gold standard stop guessing and plate it
play

ORIF is the Gold Standard: Stop Guessing and Plate it! Michael D. - PowerPoint PPT Presentation

ORIF is the Gold Standard: Stop Guessing and Plate it! Michael D. McKee, MD, FRCS(C) Professor and Chair, Department of Orthopaedic Surgery University of Arizona, College of Medicine, Phoenix, AZ Disclosure Studies supported


  1. ORIF is the Gold Standard: Stop Guessing and Plate it! Michael D. McKee, MD, FRCS(C) • Professor and Chair, Department of Orthopaedic Surgery • University of Arizona, College of Medicine, Phoenix, AZ •

  2. Disclosure • Studies supported by: - OTA, COA, ASES - Zimmer Inc. - Stryker, Olympus Biotech, AO • I am a consultant for Stryker, Acumed, Zimmer, ITS • Receive royalties from Stryker (plates), LWW, Springer (publishers)

  3. 1994 • We will give you a sling and everything should be fine.

  4. Clavicle nonunion

  5. Nonunion Robinson 2014 1 94 36 98 54.5% 0.21 (0.01, 0.75) Ahrens 2017 1 131 16 123 24.4% 0.09 (0.01,0.62)

  6. RCT : Nonunion Study Plate fixation Non-operative COTS n = 132 1% 18% Robinson n = 202 1% 28% Ahrens n = 302 1% 15%

  7. Nail versus Plate RCT • Plate fixation versus intramedullary nailing of completely displaced midshaft fractures of the clavicle: a prospective RCT • Fuglesang HFS et. al. BJJ 2017 • 123 patients, generally good results • Plate better early, IM nail less infection, OR time

  8. Fixing a Clavicle Fracture is a Finesse Operation With a Narrow Risk-Benefit Ratio

  9. Surgical Risk-Benefit Ratio • Life saving • Improves U/E function • Non-op Rx bad • Non-op Rx ok • Indestructible • Can fall apart • Reconstruction • Reconstruction difficult reasonable • Ratio: ++++ • Ratio: +

  10. Conclusions - displaced midshaft fracture of the clavicle • With non-op care, nonunion risk is approximately 15%-20% • The nonunion rate following ORIF is 1-2 % • ORIF provides more rapid return to function / activity • ORIF is superior to non-operative care in select cases • Most patients do well with non-operative treatment, but not all, and we continue to pursue prognostic factors

Recommend


More recommend